Endocrine Abstracts

Introduction: Childhood obesity has reached epidemic levels in developed as well as in developing countries. According to WHO data, an increasing number of low- and middle-income countries are now facing the "double burden" of obesity and overweightness. This problem is increasing aggressively in urban settings. This rise has occurred similarly among boys and girls. In 2016, 18% of girls and 19% of boys were overweight. In comparison, two data illustrate the pandemic s...

Obesity is the modern medical problem. According to the WHO expert panel the prevalence of obese population worldwide is 300 million and overweight is 750 million.In the first trimester of 2007, we studied the obese patients in the Iv. Javakhishvili State Medical University’s Department of Endocrinology. The objective of our research was to study the course of subclinical hypothyroidism adjunct with severe obesity, its diagnostic criteria and treatm...

The Case Study: We report the case of a 68-year-old female referred to the E.R. department with severe neurological problems. Patient’s neurological status revealed that patient was disoriented in time and place, with emotional irritability and an asymmetric eye fissure, and not feeling well without any obvious reason. A preliminary CT scan with I/V contrast was done and acute neurological damage was excluded. In the lab, there were: hypokalemia, hypomagnesemia, increased...

The therapy of hyperprolactinemia with dopamine agonists (DAs) is highly effective in the majority of cases (1). However, some patients fail to achieve normal prolactin levels and develop drug resistance towards prescribed medicine. This case study describes a medical history of The Georgian National Institute of Endocrinology patient, with a drug-resistant hyperprolactinemia and inability to conceive. The patient’s MRI scan result has not indicated incidence of pr...

The hyperprolactinemic disorder is a syndrome of prolactin hypersecretion. The syndrome is more prevalent in women than in men, but lately accidence of the syndrome disease tends to increase in men. Hyperprolactinemic disorder mostly affects men at the age range 40–59 years. Patients at the physician’s consultation have following complaints: erectile dysfunction, infertility, libido reduction, rarely gynecomastia.Sixteen patients were examined ...